Skip to Content

Morningstar Runs the Numbers

We take a numerical look through this week's Morningstar research. Plus, our most popular articles and videos for the week ended March 29.

Inspired by Harper's Index (with a tip of the hat to FiveThirtyEight's Significant Digits blog), Morningstar Runs the Numbers uses a numbers-based approach to highlight recent Morningstar research, along with some outside news stories.

3 Christine Benz says if you find yourself "crazy busy," then uncomplicating your portfolio is mission-critical. She says long-term index funds work well with the right allocations. She created three minimalist portfolios for savers.

6 Karen Wallace looks at six situations that might be appropriate for using your emergency fund. She suggests asking yourself how you would feel if you lost your job and didn't have any income after you had spent your emergency fund. Would you regret the expenditure and wish you had waited? If so, think before you spend.

11 Susan Dziubinski says intermediate-term bond funds raked in $15.5 billion in assets last month. She found 11 Gold-rated intermediate-term bond funds that can provide ballast to a portfolio no matter your life stage.

5 Twice a year, Morningstar's manager research analysts publish Morningstar Prospects, a list of up-and-coming or under-the-radar investment strategies that are not currently covered by the research group but might be in the future. Christopher Franz writes about five intriguing options.

$327 Karen Andersen looks at Biogen BIIB, a wide-moat neurology innovator. Even after recent failed drug trials, we think the company is undervalued. We lowered our Biogen fair value estimate to $327 per share from $385 following the news that both phase 3 trials of Alzheimer's drug aducanumab are being discontinued.

Most Popular Articles

  • 3 Retirement Bucket Portfolios for Minimalists
  • 11 Great Core Bond Funds
  • 16 'Sweet' Stocks
  • 3 Retirement Saver Portfolios for Minimalists
  • These Prospects Are Worth a Look

Most Popular Videos

  • Vanguard's LifeStrategy Target-Risk Series Has an Edge
  • HSAs Offer Another Path to Tax Deductions
  • Defense and Aerospace Opportunities for Dividend-Seekers
  • 2 Gold Funds for Non-U.S. Exposure
  • What Is Lyft Worth?

Most Requested Stock Quotes Apple Boeing AT&T Biogen CVS

Most Requested Fund Quotes Vanguard 500 Index Vanguard Total Stock Market Index Fidelity Contrafund Dodge & Cox Stock T. Rowe Price Blue Chip Growth

Most Requested ETF Quotes Vanguard Total Stock Market ETF SPDR S&P 500 ETF Vanguard S&P 500 ETF Vanguard High Dividend Yield ETF Vanguard Dividend Appreciation ETF

Twice a year, Morningstar's manager research analysts publish Morningstar Prospects, a list of up-and-coming or under-the-radar investment strategies that are not currently covered by the research group but might be in the future.

Sponsor Center